ALXN
Alexion Pharmaceuticals, Inc.
EVP and Chief Compliance Officer Indrani Lall Franchini sold $308K of Alexion Pharmaceuticals, Inc.
Sold$307,729
$118.13Price
2,605Shares
−8%Stake
What ALXN did after the filing
Prices for ALXN after this filing aren't in yet.
Traded Wed, Nov 28. Filed Fri, Nov 30, 1:15 PM ET, during the session. Not investment advice.